Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

157.54 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Mar 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Optimism Building for Advancing Pancreatic Cancer Treatment Therapies
EQNX::TICKER_START (NASDAQ:ONCY),(NYSE:RCUS),(NASDAQ:AZN),(NYSE:BMY),(NYSE:ABBV) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures Product Safety
Biotech Space Offers Reward In 2023 Despite Economic Risks
Despite the economic headwinds, the mid-to long-term outlook for the biotech space remains strong, and investors who are able to take advantage of undervalued biotech stocks may be well-positioned for... 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Where AbbVie Stands With Analysts
 
Via Benzinga
Credit Suisse Says AbbVie's Humira Patent Cliff Could Provide Momentum to Boost Growth
 
Via Benzinga
Analyst Ratings for AbbVie
 
Via Benzinga
3 Dividend Stocks to Buy in Case the Santa Rally Doesn’t Come
In case we don't see a holiday boost, stuff your own stocking with dividend income this Christmas with these three dividend stocks to buy. 
Via InvestorPlace
3 Top Dividend Kings to Buy for the Long Haul
Dividend stocks are an easy option to boost income. 
Via The Motley Fool
The Most Popular Stocks Millennial And Gen-Z Are Investing In
Over the next 25 years Millennials and Gen Z will inherit nearly $70 trillion from their grandparents and parents. But many of them are not waiting to start investing in stocks. So what stocks are they... 
Via Talk Markets
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023
Pfizer's revenue growth is far from over. 
Via The Motley Fool
8 Dividend Aristocrats to Buy Now for a Lifetime of Passive Income
Dividend stocks are a great way to protect against a downturn and these are the cream of the crop. 
Via The Motley Fool
What 8 Analyst Ratings Have To Say About AbbVie
 
Via Benzinga
What Does AbbVie's Debt Look Like?
Over the past three months, shares of AbbVie's Inc. (NYSE:ABBV) rose by 11.27%. Before having a look at the importance of debt, let's look at how much debt AbbVie's has. 
Via Benzinga
Better Dividend Stock: AbbVie or Viatris?
These pharmaceutical companies are profitable and offer above-average dividends. 
Via The Motley Fool
3 Dividend Stocks to Hold Forever
These businesses -- and dividends -- are built to last. 
Via The Motley Fool
Is Now the Time for Income Investors to Buy This Big Pharma Stock?
This drugmaker is among the most dominant pharmaceutical companies in the world. 
Via The Motley Fool
Could an Investment in AbbVie Give You $10,000 in Annual Dividend Income by Retirement?
This is a stock that rewards long-term investors through continual dividend increases. 
Via The Motley Fool
Want $10,000 in Annual Dividend Income by Retirement? Here's How Much You Should Invest in AbbVie Today.
This is a stock that rewards long-term investors through continual dividend increases. 
Via The Motley Fool
2 Safe Dividend Stocks to Buy Hand Over Fist
These businesses may not be "exciting," but that's not such a bad thing right now. 
Via The Motley Fool
AbbVie Boosts Its Dividend: Is the Dividend King a Buy?
Shares of the pharmaceutical stock have left the S&P 500 index in the dust so far this year. 
Via The Motley Fool
AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
The pharmaceutical company's golden goose is about to stop laying golden eggs, but that won't be a permanent problem. 
Via The Motley Fool
Want Passive Income in 2023? Buy These Dividend Kings
These stocks offer you a gift: recurrent income just for owning them. 
Via The Motley Fool
3 Top Dividend Stocks to Buy Now With Yields of 3.4% or More
These stocks offer attractive yields now, and investors can look forward to lots of payout raises. 
Via The Motley Fool
If You Invested $5,000 In InMode Stock In 2020, Here's How Much Money You'd Have Today
There's even more growth on the way -- and likely soon. 
Via The Motley Fool
2 Breakout Growth Stocks to Buy for the Long Haul
These two Russell 1000 members know how to grow revenue. 
Via The Motley Fool
MarketBeat: Week in Review 11/14 – 11/18
This week, investors digested negative news from the retail sector and the Fed and next week's abbreviated trading week won't bring much new news. 
Via MarketBeat
Topics Economy Workforce
Exposures Economy Interest Rates Layoff
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.